Cure My Disease

Don't miss your cure!

 Log in / Sign up

Coloring away the baby blues: mandala therapy tested for postpartum moms

NCT ID NCT07448636

Symptom relief Sponsor: Nuh Naci Yazgan University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether coloring mandalas (circular patterns) can help reduce anxiety and tiredness, and improve breastfeeding confidence and mother-baby bonding in women who had a C-section. About 140 new mothers will either color mandalas twice a week for 5 weeks or receive standard care. Researchers will measure their anxiety, fatigue, breastfeeding self-belief, and attachment to their baby at several points over 6 weeks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 140 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Mar 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Being 18 years of age or older * Having had a cesarean delivery after the 37th week of gestation * The baby being with the mother and the mother being able to breastfeed * Volunteering to participate in the study * Having a planned cesarean section Exclusion Criteria: * The mother is currently or has previously received psychiatric treatment. * The mother has a physical disability in her upper extremities. * The mother has a vision problem. * The newborn has a congenital anomaly. * The newborn experienced an obstetric complication requiring immediate hospitalization after birth (hemorrhage, infection, bladder damage, preeclampsia, etc.). Criteria for terminating the study: * The baby or mother has a medical condition requiring hospitalization within 6 weeks postpartum. * Communication with the mother is not possible within 6 weeks postpartum

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Mandala coloring are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety disorder Fatigue puerperal disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Mandala coloring Postpartum

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Nuh Naci Yazgan University

    Kayseri, Kayseri, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.